Unknown

Dataset Information

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport.


ABSTRACT: Metformin is currently the most prescribed drug for treatment of type 2 diabetes mellitus in humans. It has been well established that long-term treatment with metformin improves glucose tolerance in mice by inhibiting hepatic gluconeogenesis. Interestingly, a single dose of orally administered metformin acutely lowers blood glucose levels, however, little is known about the mechanism involved in this effect. Glucose tolerance, as assessed by the glucose tolerance test, was improved in response to prior oral metformin administration when compared to vehicle-treated mice, irrespective of whether the animals were fed either the standard or high-fat diet. Blood glucose-lowering effects of acutely administered metformin were also observed in mice lacking functional AMP-activated protein kinase

SUBMITTER: Horakova O 

PROVIDER: S-EPMC6468119 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature